Mark Mancini

Learn More
Circulating levels of galectin-3 (Gal-3), a marker of cardiac fibrosis and remodeling, contribute to the risk stratification of patients with heart failure (HF). The aim of our study was to determine the analytical validity and clinical validity of a novel automated Gal-3 assay in HF patients with reduced ejection fraction. We showed an excellent agreement(More)
OBJECTIVE To report our experience with single-site robotic platform for IS3000 "Da Vinci" Si Surgical System to perform robotic single site hysterectomy (RSS-H), and to compare peri-operative results with a historical series of laparoendoscopic single site hysterectomies (LESS-H). METHODS This is a retrospective case-control study, performed at the(More)
OBJECTIVES Galectin-3 (Gal-3) testing is emerging as a valuable tool for the prognosis of heart failure (HF). Our objectives were to determine the clinical validity and cost-effectiveness of the recently developed ARCHITECT Gal-3 automated immunoassay. DESIGN AND METHODS Gal-3 levels were measured in HF patients with reduced left ventricular ejection(More)
Trauma of the foot and ankle is commonly seen in the emergency unit. Nearly all of these patients undergo radiography even though only approximately 15% have clinically significant fractures. The Ottawa ankle rules (OARs) have been designed to reduce the number of unnecessary radiographs ordered for these patients. The objective of this study was to(More)
A long-term dialysis patient with end-stage renal disease (ESRD) also referred to as chronic kidney disease (CKD) due to IgA nephropathy complicated by severe secondary hyperparathyroidism and renal osteodystrophy was successfully treated with dental implant-supported fixed prostheses. Phosphate binders, vitamin D, calcium cinacalcet calcimimetic therapy,(More)
  • 1